SLIT2 is epigenetically silenced in ovarian cancers and suppresses growth when activated

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 3, 2011, Pages 791-795

  Qiu, Haifeng ^a   Zhu, Jiezhi ^b   Yu, Jinjin ^a   Pu, Hong ^a   Dong, Ruofan ^a  

^a Soochow University   (China)

^b CHANGZHI MEDICAL COLLEGE   (China)

Author keywords

Hypermethylation; Ovarian cancer; Tumor suppressor gene

Indexed keywords

EID: 79958795295     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Astuti D, Da Silva NF, Dallol A, et al.(2004) SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma. Br J Cancer, 90, 515-521.
2. Bol GM, Suijkerbuijk KP, Bart J, et al.(2010) Methylation profiles of hereditary and sporadic ovarian cancer. Histopathology, 57, 63-370.
3. Brose K, Bland KS, Wang KH, et al.(1999) Slit proteins bind Robo receptors and have an evolutionarily conserved role in repulsive axon guidance. Cell, 96,795-806.
4. Brose K, Tessier-Lavigne M(2000) Slit proteins: key regulators of axon guidance, axonal branching, and cell migration. Curr Opin Neurobiol, 10, 95-102.
5. Chan KY, Ozcelik H, Cheung AN, et al.(2002) Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer. Cancer Res, 62, 4151-4156.
6. Chiang JW, Karlan BY, Cass L, et al.(2006) BRCA1 promoter methylation predicts adverse ovarian cancer prognosis. Gynecol Oncol, 101, 403-410.
7. Dallol A, Da Silva NF, Viacava P, et al.(2002) SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers. Cancer Res, 62,5874-5880.
8. Dallol A, Krex D, Hesson L, et al.(2003) Frequent epigenetic inactivation of the SLIT2 gene in gliomas. Oncogene, 22, 4611-4616.
9. Dallol A, Morton D, Maher ER, et al.(2003) SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells. Cancer Res,63,1054-1058.
10. Dunwell TL, Dickinson RE, Stankovic T, et al.(2009) Frequent epigenetic inactivation of the SLIT2 gene in chronic and acute lymphocytic leukemia. Epigenetics, 4, 265-269.
11. Farnebo M, Bykov VJ, Wiman KG(2010) The p53 tumor suppressor: a master regulator of diverse cellular processes and therapeutic target in cancer. Biochem Biophys Res Commun, 396,85-89.
12. Fukuhara H, Kuramochi M, Fukami T, et al.(2002) Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer. Jpn J Cancer Res,93, 605-609.
13. Georgas K, Burridge L, Smith K, et al.(1999) Assignment of the human slit homologue SLIT2 to human chromosome band 4p15.2. Cytogenet Cell Genet, 86, 246-247.
14. Hoebeeck J, Michels E, Pattyn F, et al.(2009) Aberrant methylation of candidate tumor suppressor genes in neuroblastoma. Cancer Lett, 273,336-346.
15. Jin J, You H, Yu B, et al.(2009) Epigenetic inactivation of SLIT2 in human hepatocellular carcinomas. Biochem Biophys Res ommun, 379, 86-91.
16. Jones PA, Laird PW(1999) Cancer epigenetics comes of age. Nat Genet, 21,163-167.
17. Kim HK, Zhang H, Li H, et al.(2008) Slit2 inhibits growth and metastasis of fibrosarcoma and squamous cell carcinoma. eoplasia,10,1411-1420.
18. Liu D, Hou J, Hu X, et al.(2006) Neuronal chemorepellent Slit2 inhibits vascular smooth muscle cell migration by suppressing small GTPase Rac1 activation. Circ Res,98, 480-489.
19. Maehama T(2007) PTEN: its deregulation and tumorigenesis. Biol Pharm Bull, 30,1624-1627.
20. Marlow R, Strickland P, Lee JS, et al.(2008) SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. Cancer Res,68,7819-7827.
21. Narayan G, Goparaju C, Arias-Pulido H, et al.(2006) Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression. Mol Cancer, 5, 16.
22. Qiu H, Zhu J, Yuan C, et al.(2010) Frequent hypermethylation and loss of heterozygosity of the testis derived transcript gene in ovarian cancer. Cancer Sci,101,1255-1260.
23. Schondorf T, Ebert MP, Hoffmann J, et al.(2004) Hypermethylation of the PTEN gene in ovarian cancer cell lines. Cancer Lett, 07,215-220.
24. Sharma G, Mirza S, Prasad CP, et al.(2007) Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients. Life Sci, 80,1873-1881.
25. Simin K, Wu H, Lu L, et al.(2004) pRb inactivation in mammary cells reveals common mechanisms for tumor initiation and progression in divergent epithelia. PLoS Biol, 2, E22.
26. Tseng RC, Lee SH, Hsu HS, et al.(2010) SLIT2 attenuation during lung cancer progression deregulates beta-catenin and E-cadherin and associates with poor prognosis. Cancer Res,70,543-551.
27. Wang KH, Brose K, Arnott D, et al.(1999) Biochemical purification of a mammalian slit protein as a positive regulator of sensory axon elongation and branching. Cell, 96,771-784.
28. van Es JH, Giles RH, Clevers HC(2001) The many faces of the tumor suppressor gene APC. Exp Cell Res,264,126-134.
29. Zhang Q, Ying J, Zhang K, et al.(2007) Aberrant methylation of the 8p22 tumor suppressor gene DLC1 in renal cell carcinoma. Cancer Lett, 249, 220-226.